• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶活性在激素诱导的乳腺肿瘤消退中的作用。

Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression.

作者信息

Simian Marina, Molinolo Alfredo, Lanari Claudia

机构信息

Laboratorio de Carcinogénesis Hormonal, Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.

出版信息

Am J Pathol. 2006 Jan;168(1):270-9. doi: 10.2353/ajpath.2006.050012.

DOI:10.2353/ajpath.2006.050012
PMID:16400029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1592671/
Abstract

Proteolytic activity and remodeling of the extracellular matrix are important players in tumor progression. However, to date the role of the extracellular matrix in tumor regression remains unresolved. To address this, we used a progesterone-dependent in vivo mouse mammary tumor line, C4-HD, which regresses in response to hormone therapy. Within the first 72 hours of treatment, massive apoptosis was accompanied by changes in the staining patterns of laminin and collagens I, III, and IV. We thus hypothesized that an increase in matrix metalloproteinase (MMP) activity could be involved in this process. This indeed was the case as the activities of MMP-2, -9, and -3 increased in regressing tumors, coinciding with the peak of apoptosis. Moreover, cell-cell interactions were disrupted during early hours of regression with E-cadherin levels reduced and fragmentation products detected during regression. Analysis of beta-catenin revealed that although total levels within the tissue did not change, this molecule switched from being involved in cell-cell adhesion in the growing tumor to being expressed in the reactive stroma during regression. Our data provide a novel role for proteolytic activity in tumor regression and question the underlying principle for using MMP inhibitors in cancer treatment.

摘要

蛋白水解活性和细胞外基质重塑是肿瘤进展中的重要因素。然而,迄今为止,细胞外基质在肿瘤消退中的作用仍未明确。为了解决这个问题,我们使用了一种依赖孕酮的体内小鼠乳腺肿瘤模型C4-HD,该模型在激素治疗后会消退。在治疗的前72小时内,大量细胞凋亡伴随着层粘连蛋白以及I、III和IV型胶原蛋白染色模式的变化。因此,我们推测基质金属蛋白酶(MMP)活性的增加可能参与了这一过程。实际情况确实如此,在消退的肿瘤中,MMP-2、-9和-3的活性增加,与细胞凋亡的峰值一致。此外,在消退的早期阶段,细胞间相互作用被破坏,E-钙黏蛋白水平降低,且在消退过程中检测到其裂解产物。对β-连环蛋白的分析表明,尽管组织内的总水平没有变化,但该分子在生长中的肿瘤中参与细胞间黏附,而在消退过程中则在反应性基质中表达。我们的数据揭示了蛋白水解活性在肿瘤消退中的新作用,并对癌症治疗中使用MMP抑制剂的潜在原则提出了质疑。

相似文献

1
Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression.基质金属蛋白酶活性在激素诱导的乳腺肿瘤消退中的作用。
Am J Pathol. 2006 Jan;168(1):270-9. doi: 10.2353/ajpath.2006.050012.
2
Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.PI3Kγ 的缺失增强了 cAMP 依赖性 MMP 对心肌 N-钙黏蛋白黏附复合物和细胞外基质的重塑,以响应早期生物力学应激。
Circ Res. 2010 Nov 12;107(10):1275-89. doi: 10.1161/CIRCRESAHA.110.229054. Epub 2010 Sep 16.
3
Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.基质金属蛋白酶在Wnt1诱导的乳腺肿瘤发生过程中发挥着积极作用。
Cancer Res. 2006 Mar 1;66(5):2691-9. doi: 10.1158/0008-5472.CAN-05-2919.
4
Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.与源自其异种移植的、已建立的肿瘤细胞系的对应物相比,自发性髓母细胞瘤/原始神经外胚层肿瘤的基质金属蛋白酶表达谱存在显著差异。
In Vivo. 2000 Sep-Oct;14(5):675-82.
5
Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.激肽释放酶6诱导E-钙黏蛋白脱落,并促进细胞增殖、迁移和侵袭。
Cancer Res. 2007 Sep 1;67(17):8198-206. doi: 10.1158/0008-5472.CAN-07-0607.
6
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.人黑色素瘤细胞系和异种移植瘤中的基质金属蛋白酶:活化基质金属蛋白酶-2(MMP-2)表达增加与黑色素瘤进展相关。
Br J Cancer. 1999 Nov;81(5):774-82. doi: 10.1038/sj.bjc.6690763.
7
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.低剂量α干扰素治疗可恢复人膀胱移行细胞癌中基质金属蛋白酶-9与E-钙黏蛋白表达之间的平衡。
Clin Cancer Res. 2001 Sep;7(9):2840-53.
8
Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.活化白细胞黏附分子(ALCAM/CD166/MEMD)是侵袭性生长中的一个新角色,它控制基质金属蛋白酶的活性。
Cancer Res. 2005 Oct 1;65(19):8801-8. doi: 10.1158/0008-5472.CAN-05-0378.
9
Adhesion and protease activity in cell lines from human salivary gland tumors are regulated by the laminin-derived peptide AG73, syndecan-1 and beta1 integrin.人涎腺肿瘤细胞系中的黏附及蛋白酶活性受层粘连蛋白衍生肽AG73、多配体蛋白聚糖-1和β1整合素调控。
Matrix Biol. 2008 Jun;27(5):402-19. doi: 10.1016/j.matbio.2008.02.007. Epub 2008 Feb 29.
10
Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.nm23-H1 的转染增加了β-连环蛋白、E-钙黏蛋白和基质金属蛋白酶组织抑制因子-1(TIMP-1)的表达,降低了基质金属蛋白酶-2(MMP-2)、CD44v6 和血管内皮生长因子(VEGF)的表达,并抑制了人非小细胞肺癌细胞系 L9981 的转移潜能。
Neoplasma. 2006;53(6):530-7.

引用本文的文献

1
Antiprogestins in gynecological diseases.抗孕激素在妇科疾病中的应用
Reproduction. 2015 Jan;149(1):R15-33. doi: 10.1530/REP-14-0416. Epub 2014 Sep 24.
2
The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.纳米化疗颗粒与米非司酮联合使用的有效性取决于乳腺癌临床前模型中的PR异构体比例。
Oncotarget. 2014 May 30;5(10):3246-60. doi: 10.18632/oncotarget.1922.
3
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.孕激素受体与激活蛋白1、信号转导和转录激活因子3以及ErbB-2共同组装转录复合物,调控乳腺癌生长并预测内分泌治疗反应。
Breast Cancer Res. 2013 Dec 17;15(6):R118. doi: 10.1186/bcr3587.
4
Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice.在裸鼠异种移植模型中,人三阴性乳腺癌细胞系向淋巴结转移过程中的蛋白表达变化。
Cancer Biol Ther. 2012 Sep;13(11):1123-40. doi: 10.4161/cbt.21187. Epub 2012 Jul 24.
5
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.孕激素介导的致癌信号下调肿瘤抑制 miR-16 促进乳腺癌发生。
Breast Cancer Res. 2012 May 14;14(3):R77. doi: 10.1186/bcr3187.
6
Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice.乳腺癌对 PI3K 和 MEK 抑制剂的反应。利用 3D 培养系统研究与小鼠激素独立性相关的途径。
PLoS One. 2010 May 26;5(5):e10786. doi: 10.1371/journal.pone.0010786.
7
MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis.MMP-7 介导 N-钙黏蛋白的裂解并促进平滑肌细胞凋亡。
Cardiovasc Res. 2010 Jul 1;87(1):137-46. doi: 10.1093/cvr/cvq042. Epub 2010 Feb 5.
8
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth.在这里调节蛋白/ErbB-2通过孕酮受体信号传导的共同作用激活Stat3,从而推动乳腺癌生长。
Mol Cell Biol. 2009 Mar;29(5):1249-65. doi: 10.1128/MCB.00853-08. Epub 2008 Dec 22.
9
Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.对氨基乙酰丙酸光动力疗法耐药的细胞中转移表型降低。
Cancer Lett. 2008 Nov 28;271(2):342-51. doi: 10.1016/j.canlet.2008.06.023. Epub 2008 Jul 26.
10
The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.胶原酶-1(基质金属蛋白酶-1,MMP-1)基因启动子多态性-1607/2G与结直肠癌患者的良好预后相关。
Br J Cancer. 2007 Mar 12;96(5):783-92. doi: 10.1038/sj.bjc.6603630. Epub 2007 Feb 20.

本文引用的文献

1
International variation.国际差异。
Oncogene. 2004 Aug 23;23(38):6329-40. doi: 10.1038/sj.onc.1207726.
2
Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing.在伤口愈合的增殖阶段,生长因子调节成纤维细胞中β-连环蛋白介导的TCF依赖性转录激活。
Exp Cell Res. 2004 Feb 15;293(2):267-74. doi: 10.1016/j.yexcr.2003.09.029.
3
The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer.E-钙黏蛋白80 kDa片段在前列腺癌转移进展中的作用。
Clin Cancer Res. 2003 Dec 15;9(17):6447-52.
4
Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen.来曲唑或他莫昔芬新辅助治疗后乳腺癌反应的病理特征。
Eur J Cancer. 2003 Mar;39(4):462-8. doi: 10.1016/s0959-8049(02)00600-7.
5
[Review part I: basic mechanisms of cutaneous woundhealing].[综述第一部分:皮肤伤口愈合的基本机制]
Laryngorhinootologie. 2003 Jan;82(1):31-5. doi: 10.1055/s-2003-36908.
6
Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma.人类乳腺癌中的上皮-间质转化可产生非恶性基质。
Am J Pathol. 2003 Feb;162(2):391-402. doi: 10.1016/S0002-9440(10)63834-5.
7
The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells.钙蛋白酶在前列腺和乳腺上皮细胞中E-钙黏蛋白蛋白水解切割中的作用。
J Biol Chem. 2003 Jan 10;278(2):1372-9. doi: 10.1074/jbc.M208772200. Epub 2002 Oct 19.
8
p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas.
Carcinogenesis. 2002 May;23(5):749-58. doi: 10.1093/carcin/23.5.749.
9
New functions for the matrix metalloproteinases in cancer progression.基质金属蛋白酶在癌症进展中的新功能。
Nat Rev Cancer. 2002 Mar;2(3):161-74. doi: 10.1038/nrc745.
10
Matrix metalloproteinase inhibitors and cancer: trials and tribulations.基质金属蛋白酶抑制剂与癌症:试验与磨难
Science. 2002 Mar 29;295(5564):2387-92. doi: 10.1126/science.1067100.